4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-4,7-diazaspiro[2.5]oct-7-yl]-6-(methylsulfonyl)-8-nitro- manufacturers
|
| | 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-4,7-diazaspiro[2.5]oct-7-yl]-6-(methylsulfonyl)-8-nitro- Basic information |
| | 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-4,7-diazaspiro[2.5]oct-7-yl]-6-(methylsulfonyl)-8-nitro- Chemical Properties |
| Boiling point | 711.6±70.0 °C(Predicted) | | density | 1.57±0.1 g/cm3(Predicted) | | pka | 7.19±0.20(Predicted) |
| | 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-4,7-diazaspiro[2.5]oct-7-yl]-6-(methylsulfonyl)-8-nitro- Usage And Synthesis |
| Uses | Antitubercular agent-32 is a derivate of Benzothiazinone (HY-13579A), inhibits M. tuberculosis, and shows improved metabolic stability and enhanced water solubility. Antitubercular agent-32 exerts antitubercular effect by targeting decaprenylphosphoryl-β-D-ribose 2’-oxidase (DprE1, IC50=3.9 μM)[1]. | | References | [1] Shi R, et al. Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents. ACS Med Chem Lett. 2022 Mar 10;13(4):593-598. DOI:10.1021/acsmedchemlett.1c00652 |
| | 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-4,7-diazaspiro[2.5]oct-7-yl]-6-(methylsulfonyl)-8-nitro- Preparation Products And Raw materials |
|